The comparative study with lixisenatide /glargine combination therapy versus twice-daily premixed insulin therapy/DPP-4 inhibitor on glycemic variability, and feeding behavior in obese patients with type 2 diabetes mellitus
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.